[1]王吉利,万雷,张志海,等.抑制Dickkopf-1和Sclerostin表达对人成骨肉瘤细胞MG63骨代谢调节相关蛋白表达水平的影响[J].中医正骨,2016,28(09):13-18.
 WANG Jili,WAN Lei,ZHANG Zhihai,et al.Effect of suppression of Dickkopf-1 and Sclerostin expression on bone metabolism regulatory protein expression levels in human osteosarcoma MG63 cells[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(09):13-18.
点击复制

抑制Dickkopf-1和Sclerostin表达对人成骨肉瘤细胞MG63骨代谢调节相关蛋白表达水平的影响()
分享到:

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第28卷
期数:
2016年09期
页码:
13-18
栏目:
基础研究
出版日期:
2016-09-20

文章信息/Info

Title:
Effect of suppression of Dickkopf-1 and Sclerostin expression on bone metabolism regulatory protein expression levels in human osteosarcoma MG63 cells
作者:
王吉利1万雷1张志海1黄宏兴1黄红2肖本浩1魏合伟1曾国勇3
1.广州中医药大学第三附属医院,广东 广州 510240; 2.广州中医药大学,广东 广州 510006; 3.广东省茂名市中医院,广东 茂名 525000
Author(s):
WANG Jili1WAN Lei1ZHANG Zhihai1HUANG Hongxing1HUANG Hong2XIAO Benhao1WEI Hewei1ZENG Guoyong3
1.The Third Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine,Guangzhou 510240,Guangdong,China2.Guangzhou University of Traditional Chinese Medicine,Guangzhou 510006,Guangdong,China3.Maoming Hospital of Traditional Chinese Medici
关键词:
骨质疏松 基因沉默 Dickkopf-1 Sclerostin 腺病毒 MG63细胞
Keywords:
osteoporosis gene silencing Dickkopf-1 Serostin adenovirus MG63 cells
摘要:
目的:观察抑制Dickkopf-1和Sclerostin表达对人成骨肉瘤细胞MG63骨代谢调节相关蛋白表达水平的影响。方法:培养MG63细胞,构建沉默Dickkopf-1重组腺病毒载体和沉默Sclerostin重组腺病毒载体。将培养好的MG63细胞(每孔2×105个)分为4组,Scr组以Scr腺病毒转染、Dickkopf-1组以沉默Dickkopf-1重组腺病毒载体转染、Sclerostin组以沉默Sclerostin重组腺病毒载体转染、Dickkopf-1+Sclerostin组以沉默Dickkopf-1重组腺病毒载体和沉默Sclerostin重组腺病毒载体共同转染。各组MG63细胞转染重组腺病毒48 h后以Western Blot法测定各组细胞中骨保护素(osteoprotegerin,OPG)、低密度脂蛋白受体相关蛋白-5(low density lipoprotein receptor-related protein-5,Lrp-5)、骨形态发生蛋白-2(bone morphogenetic protein-2,BMP-2)、成纤维细胞生长因子-2(fibroblast growth factor-2,FGF-2)、Runt相关转录因子-2(Runt-related transcription factor-2,Runx-2)、结缔组织生长因子(connective tissue growth factor,CTGF)、骨桥蛋白(osteopontin,OPN)、肿瘤坏死因子-α(tumor necrosis factor-α,TNF-α)等骨代谢调节相关蛋白的表达水平。结果:Dickkopf-1组的OPG表达量与Scr组、Sclerostin组比较,组间差异均无统计学意义(P=0.050,P=0.196); Sclerostin组、Dickkopf-1+Sclerostin组的OPG表达量均高于Scr组(P=0.010,P=0.000); Dickkopf-1组和Sclerostin组的OPG表达量均低于Dickkopf-1+Sclerostin组(P=0.000,P=0.000)。Dickkopf-1组、Sclerostin组、Dickkopf-1+Sclerostin组的Lrp-5表达量均高于Scr组(P=0.012,P=0.010,P=0.000); Dickkopf-1组的Lrp-5表达量与Sclerostin组比较,差异无统计学意义(P=0.119); Dickkopf-1组和Sclerostin组的Lrp-5表达量均低于Dickkopf-1+Sclerostin组(P=0.000,P=0.000)。Dickkopf-1组的BMP-2表达量与Scr组比较,差异无统计学意义(P=0.185); Dickkopf-1组的BMP-2表达量低于Sclerostin组(P=0.037); Dickkopf-1组和Sclerostin组的BMP-2表达量均低于Dickkopf-1+Sclerostin组(P=0.000,P=0.000)。Dickkopf-1组、Sclerostin组、Dickkopf-1+Sclerostin组的FGF-2表达量均高于Scr组(P=0.010,P=0.000,P=0.000); Dickkopf-1组的FGF-2表达量低于Sclerostin组和Dickkopf-1+Sclerostin组(P=0.000,P=0.000); Sclerostin组的FGF-2表达量低于Dickkopf-1+Sclerostin组(P=0.000)。Dickkopf-1组、Sclerostin组、Dickkopf-1+Sclerostin组的Runx-2表达量均高于Scr组(P=0.000,P=0.000,P=0.000); Dickkopf-1组的Runx-2表达量低于Sclerostin组和Dickkopf-1+Sclerostin组(P=0.000,P=0.000); Sclerostin组的Runx-2表达量低于Dickkopf-1+Sclerostin组(P=0.000)。Dickkopf-1组、Sclerostin组、Dickkopf-1+Sclerostin组的CTGF表达量均高于Scr组(P=0.010,P=0.000,P=0.010); Dickkopf-1组的CTGF表达量与Sclerostin组比较,差异无统计学意义(P=0.080); Dickkopf-1组和Sclerostin组的CTGF表达量均低于Dickkopf-1+Sclerostin组(P=0.000,P=0.004)。Dickkopf-1组、Sclerostin组、Dickkopf-1+Sclerostin组的OPN表达量均高于Scr组(P=0.002,P=0.000,P=0.000); Dickkopf-1组和Dickkopf-1+Sclerostin组的OPN表达量与Sclerostin组比较,差异均无统计学意义(P=0.050,P=0.170); Dickkopf-1组的OPN表达量低于Dickkopf-1+Sclerostin组(P=0.000)。Dickkopf-1组、Sclerostin组、Dickkopf-1+Sclerostin组的TNF-α表达量均低于Scr组(P=0.000,P=0.000,P=0.000); Dickkopf-1组的TNF-α表达量高于Sclerostin组和Dickkopf-1+Sclerostin组(P=0.000,P=0.000); Sclerostin组和Dickkopf-1+Sclerostin组的TNF-α表达量比较,差异无统计学意义(P=0.125)。结论:抑制MG63细胞Dickkopf-1和Sclerostin表达,均能上调具有骨形成和双向调节作用的骨代谢调节相关蛋白表达水平、下调具有骨吸收作用的骨代谢调节相关蛋白表达水平,其中抑制Sclerostin表达对骨代谢调节相关蛋白表达水平的影响强于抑制Dickkopf-1表达,而且抑制Dickkopf-1和Sclerostin表达在调节骨代谢调节-----------------------------------------------
Abstract:
Objective:To observe the effect of suppression of Dickkopf-1 and Sclerostin expression on bone metabolism regulatory protein expression levels in human osteosarcoma MG63 cells.Methods:The MG63 cells were cultured and Dickkopf-1 silencing recombinant adenovirus vectors and Sclerostin silencing recombinant adenovirus vectors were constructed.The MG63 cells were divided into 4 groups,two hundred thousand cells in one hole,and were transfected with Scr adenovirus(Scr group),Dickkopf-1 silencing recombinant adenovirus vectors(Dickkopf-1 group),Sclerostin silencing recombinant adenovirus vectors(Sclerostin group)and Dickkopf-1 silencing recombinant adenovirus vectors combined with Sclerostin silencing recombinant adenovirus vectors(Dickkopf-1-Sclerostin group)respectively.At 48 hours after recombinant adenovirus transfection,Western Blot was used to measure the expression levels of bone metabolism regulatory protein,including osteoprotegerin(OPG),low density lipoprotein receptor-related protein-5(Lrp-5),bone morphogenetic protein-2(BMP-2),fibroblast growth factor-2(FGF-2),Runt-related transcription factor-2(Runx-2),connective tissue growth factor(CTGF),osteopontin(OPN)and tumor necrosis factor-α(TNF-α).Results:There was no statistical difference in the expression of OPG between Dickkopf-1 group and Scr group and between Dickkopf-1 group and Sclerostin group(P=0.050,P=0.196).The expression of OPG was higher in Sclerostin group and Dickkopf-1-Sclerostin group compared to Scr group(P=0.010,P=0.000),and was lower in Dickkopf-1 group and Sclerostin group compared to Dickkopf-1-Sclerostin group(P=0.000,P=0.000).The expression of Lrp-5 was higher in Dickkopf-1 group,Sclerostin group and Dickkopf-1-Sclerostin group compared to Scr group(P=0.012,P=0.010,P=0.000).There was no statistical differences in the expression of Lrp-5 between Dickkopf-1 group and Sclerostin group(P=0.119).The expression of Lrp-5 was lower in Dickkopf-1 group and Sclerostin group compared to Dickkopf-1-Sclerostin group(P=0.000,P=0.000).There was no statistical differences in the expression of BMP-2 between Dickkopf-1 group and Scr group(P=0.185).The expression of BMP-2 was lower in Dickkopf-1 group compared to Sclerostin group(P=0.037),and was lower in Dickkopf-1 group and Sclerostin group compared to Dickkopf-1-Sclerostin group(P=0.000,P=0.000).The expression of FGF-2 was higher in Dickkopf-1 group,Sclerostin group and Dickkopf-1-Sclerostin group compared to Scr group(P=0.010,P=0.000,P=0.000),and was lower in Dickkopf-1 group compared to Sclerostin group and Dickkopf-1-Sclerostin group(P=0.000,P=0.000).The expression of FGF-2 was lower in Sclerostin group compared to Dickkopf-1-Sclerostin group(P=0.000).The expression of Runx-2 was higher in Dickkopf-1 group,Sclerostin group and Dickkopf-1-Sclerostin group compared to Scr group(P=0.000,P=0.000,P=0.000).The expression of Runx-2 was lower in Dickkopf-1 group compared to Sclerostin group and Dickkopf-1-Sclerostin group(P=0.000,P=0.000),and was lower in Sclerostin group compared to Dickkopf-1-Sclerostin group(P=0.000).The expression of CTGF was higher in Dickkopf-1 group,Sclerostin group and Dickkopf-1-Sclerostin group compared to Scr group(P=0.010,P=0.000,P=0.010).There was no statistical differences in the expression of CTGF between Dickkopf-1 group and Sclerostin group(P=0.080).The expression of CTGF was lower in Dickkopf-1 group and Sclerostin group compared to Dickkopf-1-Sclerostin group(P=0.000,P=0.004).The expression of OPN was higher in Dickkopf-1 group,Sclerostin group and Dickkopf-1-Sclerostin group compared to Scr group(P=0.002,P=0.000,P=0.000).There was no statistical differences in the expression of OPN between Dickkopf-1 group and Sclerostin group and between Dickkopf-1-Sclerostin group and Sclerostin group(P=0.050,P=0.170).The expression of OPN was lower in Dickkopf-1 group compared to Dickkopf-1-Sclerostin group(P=0.000).The expression of TNF-α was lower in Dickkopf-1 group,Sclerostin group and Dickkopf-1-Sclerostin group compared to Scr group(P=0.000,P=0.000,P=0.000),and was higher in Dickkopf-1 group compared to Sclerostin group and Dickkopf-1-Sclerostin group(P=0.000,P=0.000).There was no statistical differences in the expression of TNF-α between Sclerostin group and Dickkopf-1-Sclerostin group(P=0.125).Conclusion:By suppressing the expression of Dickkopf-1 and Sclerostin in MG63 cells,the expression levels of bone metabolism regulatory proteins which has accelerating effects on bone formation and which has bidirectional regulatory effects on bone metabolism can be upregulated,and the expression levels of bone metabolism regulatory proteins which has accelerating effects on bone resorption can be downregulated.The expression levels of bone metabolism regulatory proteins are influenced more by suppression of Sclerostin expression than suppression of Dickkopf-1 expression,and the suppression of expression of Dickkopf-1 and Sclerostin has a synergistic effect on regulating the expression levels of bone metabolism regulatory proteins.

参考文献/References:

[1] Ke HZ,Richards WG,Li XD,et al.Sclerostin and dickkopf-1 as therapeutic targets in bone diseases[J].Endocr Rev,2012,33(5):747-783. [2] Macdonald BT,Joiner DM,Oyserman SM,et al.Bone mass is inversely proportional to Dkk1 levels in mice[J].Bone,2007,41(3):331-339. [3] Wang FS,Ko JY,Yeh DW,et al.Modulation of dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis,adipocytic differentiation,and bone mass loss[J].Endocrinology,2008,149(4):1793-1801. [4] Ellies DL,Viviano B,Mccarthy J,et al.Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity[J].J Bone Miner Res,2006,21(11):1738-1749. [5] Ryan ZC,Ketha H,Mcnulty MS,et al.Sclerostin alters serum vitamin D metabolite and fibroblast growth factor 23 concentrations and the urinary excretion of Calcium[J].Proc Natl Acad Sci U S A,2013,110(15):6199-6204. [6] 万雷,黄宏兴,黄红,等.过表达DKK1,Sost重组腺病毒载体的构建及其对MG63细胞和相关蛋白的影响研究[J].广州中医药大学学报,2016,33(4):578-584. [7] Rodda SJ,Mcmahon AP.Distinct roles for Hedgehog and canonical Wnt signaling in specification,differentiation and maintenance of osteoblast progenitors[J].Development,2006,133(16):3231-3244. [8] Rawadi G,Vayssière B,Dunn F,et al.BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop[J].J Bone Miner Res,2003,18(10):1842-1853. [9] LEUNGD.Adenoviral vectors[J].Meducator,2012,1(2):6. [10] Boyce BF,Hughes DE,Wright KR,et al.Recent advances in bone biology provide insight into the pathogenesis of bone diseases[J].Lab Invest,1999,79(2):83-94. [11] 许勇,王铸钢,杨桦,等.骨保护素(OPG)基因敲除小鼠发生高转换型骨质疏松和动脉钙化[J].生物化学与生物物理进展,2007,34(003):260-266. [12] Yadav VK,Ryu JH,Suda N,et al.Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum[J].Cell,2008,135(5):825-837. [13] Zhao M,Ko SY,Liu JH,et al.Inhibition of microtubule assembly in osteoblasts stimulates bone morphogenetic protein 2 expression and bone formation through transcription factor Gli2[J].Mol Cell Biol,2009,29(5):1291-1305. [14] Zoricic S,Maric I,Bobinac D,et al.Expression of bone morphogenetic proteins and cartilage-derived morphogenetic proteins during osteophyte formation in humans[J].J Anat,2003,202(Pt 3):269-277. [15] Mao B,Wu W,Davidson G,et al.Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling[J].Nature,2002,417(6889):664-667. [16] Mao B,Wu W,Li Y,et al.LDL-receptor-related protein 6 is a receptor for Dickkopf proteins[J].Nature,2001,411(6835):321-325. [17] Hess K,Ushmorov A,Fiedler J,et al.TNFalpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway[J].Bone,2009,45(2):367-376. [18] Ding J,Ghali O,Lencel P,et al.TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells[J].Life Sci,2009,84(15/16):499-504. [19] 张丽,姜丽燕,张良岩,等.CTGF 对破骨前体细胞 RAW264.7增殖及碳酸酐酶Ⅱ分化的影响[J].中国骨质疏松杂志,2014,202(2):133-136. [20] 王增田,王心,杨静,等.骨桥蛋白影响破骨细胞,成骨细胞参与骨重塑过程的研究进展[J].武警后勤学院学报:医学版,2014,23(12):1062.

相似文献/References:

[1]刘磊,万春友,全先辉,等.锁定钢板内固定结合肱骨头植骨重建治疗 肱骨近端Neer三、四部分骨折[J].中医正骨,2015,27(10):52.
[2]徐伟锋,叶健,吴连国.强骨饮对骨质疏松性股骨颈骨折患者全髋关节置换术后 血清骨代谢生化指标和骨密度的影响[J].中医正骨,2015,27(02):12.
 XU Weifeng,YE Jian,WU Lianguo.Effect of Qianggu Yin(强骨饮,QGY)on serum bone metabolism indexes and bone density after total hip arthroplasty in patients with osteoporotic femoral neck fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):12.
[3]龚江浩.股骨近端防旋髓内钉联合抗骨质疏松药物治疗 不稳定型老年股骨转子间骨折的临床观察[J].中医正骨,2015,27(04):29.
 GONG Jianghao.A combination therapy of proximal femoral nail antirotation and anti-osteoporotic drugs for the treatment of unstable femoral intertrochanteric fractures in the aged[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):29.
[4]李冠慧,李灿东,李西海,等.雌激素调控绝经后骨质疏松症骨吸收-骨形成 耦联失衡的机制[J].中医正骨,2016,28(02):36.
[5]费国芳,费红良,王金法.两种内固定方法治疗老年不稳定性股骨转子间骨折的对比研究[J].中医正骨,2016,28(05):9.
 FEI Guofang,FEI Hongliang,WANG Jinfa.Comparison of two kinds of internal fixation for treatment of unstable femoral intertrochanteric fractures in the aged[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(09):9.
[6]陈思凯,邢金明.骨水泥强化椎弓根螺钉内固定治疗老年胸腰椎压缩性骨折[J].中医正骨,2016,28(05):35.
[7]孙鹏,谭磊,阎乾,等.人工肱骨头置换术治疗老年肱骨近端Neer三、四部分骨折[J].中医正骨,2016,28(05):43.
[8]王博,吴鹏,史晓林.强骨饮对去卵巢骨质疏松大鼠骨显微结构的影响[J].中医正骨,2016,28(07):6.
 WANG Bo,WU Peng,SHI Xiaolin.A retrospective trial of postural reduction combined with percutaneous vertebroplasty versus percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(09):6.
[9]冯建军,邹浩,朱海燕,等.槲皮素对去卵巢大鼠血清骨钙素和股骨Ⅰ型胶原蛋白水平的影响[J].中医正骨,2016,28(07):10.
 FENG Jianjun,ZOU Hao,ZHU Haiyan,et al.Leverage bone grafting and pedicle screw internal fixation through posterior approach for treatment of thoracolumbar fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(09):10.
[10]张国文.肱骨近端锁定接骨板内固定治疗肱骨近端骨折[J].中医正骨,2016,28(08):50.

备注/Memo

备注/Memo:
2016-07-14收稿 2016-08-09修回
基金项目:国家自然科学基金项目(81302991,81373653); 广东省自然科学基金项目(S2013040016828,2014A030310127); 广东省科技计划项目(2013B021800058); 广州中医药大学青年英才项目(QNYC20120119); 2014广东省“优青计划”项目(yq2014041)
万雷 E-mail:gzwl802@163.com

更新日期/Last Update: 1900-01-01